Acadia Healthcare Company Inc.
| NASDAQ: ACHC |
| Healthcare / Healthcare Providers & Services / USA |
| 70.37 | +1.87 | +2.73% | Vol 600.70K | 1Y Perf 7.18% |
| Jun 24th, 2022 16:00 DELAYED |
| BID | 69.86 | ASK | 70.69 | ||
| Open | 69.31 | Previous Close | 68.50 | ||
| Pre-Market | - | After-Market | 70.37 | ||
| - - | - -% |
| Target Price | 79.42 | Analyst Rating | Moderate Buy 2.00 | |
| Potential % | 12.86 | Finscreener Ranking | ★★ 46.23 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★ 52.05 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★ 47.04 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 76.26 | Earnings Rating | Buy | |
| Market Cap | 6.37B | Earnings Date | 1st Aug 2022 | |
| Alpha | 0.01 | Standard Deviation | 0.13 | |
| Beta | 1.28 |
Today's Price Range 68.7770.65 | 52W Range 50.0776.69 | 5 Year PE Ratio Range -12.50603.80 |
Summary:
Buy
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 8.43% | ||
| 1 Month | -2.32% | ||
| 3 Months | 6.80% | ||
| 6 Months | 19.03% | ||
| 1 Year | 7.18% | ||
| 3 Years | 104.27% | ||
| 5 Years | 46.51% | ||
| 10 Years | 317.63% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -3.20 | |||
ROE last 12 Months | 9.92 | |||
ROA (5Y Avg) | -1.59 | |||
ROA last 12 Months | 5.16 | |||
ROC (5Y Avg) | 0.40 | |||
ROC last 12 Months | 7.13 | |||
Return on invested Capital Q | 1.75 | |||
Return on invested Capital Y | 2.01 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 2.90 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 24.40 | ||||
| 2.28 | ||||
| 2.47 | ||||
| 15.80 | ||||
| -13 232.40 | ||||
| 4.12 | ||||
| 19.36 | ||||
| 28.44 | ||||
| 7.37B | ||||
| Forward PE | 19.74 | |||
| PEG | 1.95 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.20 | ||||
| 1.30 | ||||
| 0.38 | ||||
| 0.63 | ||||
| 6.10 | ||||
| Leverage Ratio | 1.90 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 42.50 | ||||
| 16.40 | ||||
| 21.00 | ||||
| 6.30 | ||||
| 10.38 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 2.38B | ||||
| 26.29 | ||||
| -9.67 | ||||
| -5.38 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2022 | 0.63 | 0.67 | 6.35 |
| Q04 2021 | 0.68 | 0.67 | -1.47 |
| Q03 2021 | 0.72 | 0.72 | 0.00 |
| Q02 2021 | 0.63 | 0.71 | 12.70 |
| Q01 2021 | 0.45 | 0.47 | 4.44 |
| Q04 2020 | 0.69 | 1.13 | 63.77 |
| Q03 2020 | 0.55 | 0.68 | 23.64 |
| Q02 2020 | 0.38 | 0.54 | 42.11 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 6/2022 QR | 0.79 | 1.28 | Positive |
| 9/2022 QR | 0.80 | 0.00 | - |
| 12/2022 FY | 3.09 | 3.34 | Positive |
| 12/2023 FY | 3.35 | 0.30 | Positive |
| Next Report Date | 1st Aug 2022 |
| Estimated EPS Next Report | 0.79 |
| Estimates Count | 5 |
| EPS Growth Next 5 Years % | 12.50 |
| Volume Overview | |
|---|---|
| Volume | 600.70K |
| Shares Outstanding | 90.53K |
| Shares Float | 78.16M |
| Trades Count | 11.19K |
| Dollar Volume | 42.09M |
| Avg. Volume | 544.95K |
| Avg. Weekly Volume | 525.14K |
| Avg. Monthly Volume | 465.07K |
| Avg. Quarterly Volume | 644.64K |
Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 70.37 per share at the end of the most recent trading day (a 2.73% change compared to the prior day closing price) with a volume of 600.70K shares and market capitalization of 6.37B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.
The one-year performance of Acadia Healthcare Company Inc. stock is 7.18%, while year-to-date (YTD) performance is 15.93%. ACHC stock has a five-year performance of 46.51%. Its 52-week range is between 50.07 and 76.69, which gives ACHC stock a 52-week price range ratio of 76.26%
Acadia Healthcare Company Inc. currently has a PE ratio of 24.40, a price-to-book (PB) ratio of 2.28, a price-to-sale (PS) ratio of 2.47, a price to cashflow ratio of 15.80, a PEG ratio of 2.32, a ROA of 5.16%, a ROC of 7.13% and a ROE of 9.92%. The company’s profit margin is 10.38%, its EBITDA margin is 21.00%, and its revenue ttm is $2.38 Billion , which makes it $26.29 revenue per share.
Of the last four earnings reports from Acadia Healthcare Company Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.79 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 01st Aug 2022.
The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2), with a target price of $79.42, which is +12.86% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Acadia Healthcare Company Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.31, ATR14 : 2.36, CCI20 : 38.14, Chaikin Money Flow : 0.05, MACD : -0.54, Money Flow Index : 55.14, ROC : -1.08, RSI : 55.40, STOCH (14,3) : 84.08, STOCH RSI : 1.00, UO : 66.20, Williams %R : -15.92), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were:
Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
CEO: Debra K. Osteen
Telephone: +1 615 861-6000
Address: 6100 Tower Circle, Franklin 37067, TN, US
Number of employees: 42 800
TipRanks News for ACHC
Thu, 05 May 2022 20:35 GMT Analysts Conflicted on These Healthcare Names: Myriad Genetics (MYGN), Acadia Healthcare (ACHC) and Karyopharm Therapeutics (KPTI)
- TipRanks. All rights reserved.Thu, 05 May 2022 12:44 GMT Acadia Healthcare (ACHC) Receives a Buy from Raymond James
- TipRanks. All rights reserved.Fri, 08 Apr 2022 12:37 GMT Leerink Partners Believes Acadia Healthcare (ACHC) Still Has Room to Grow
- TipRanks. All rights reserved.Tue, 01 Mar 2022 16:35 GMT Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC), Heska (HSKA) and Reata Pharmaceuticals (RETA)
- TipRanks. All rights reserved.Tue, 01 Mar 2022 13:45 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Acadia Healthcare (ACHC), Amgen (AMGN) and Novavax (NVAX)
- TipRanks. All rights reserved.
